Back

Exercise-induced troponin I elevation is associated with alterations in regional longitudinal strain

27 August 2023 (08:15 - 08:50)
Organised by: Logo
Congress Presentation Part of: Physical inactivity and exercise Exercise ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Christine Erevik

Stavanger University Hospital, Stavanger (Norway)

6 More presentations in this session

Presentation thumbnail
Physical activity and sedentary behavior patterns in individuals with a bicuspid aortic valve compared to healthy controls
Miss B. Schreurs (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study
Doctor A. Agbaje (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Exercise-based interventions for preventing and treating cancer therapy-related cardiovascular toxicity: a systematic review and meta-analysis
Mr Z. Huang (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Physical activity and cause-specific mortality among 150,000 participants in the Mexico city prospective study
Doctor L. Friedrichs (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Normobaric hypoxia and exercise training effects on cardiac biomarkers, left ventricular function and aerobic performance in patients after myocardial infarction
Professor A. Zebrowska (Katowice, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Physical inactivity and exercise

The Event

Event poster

ESC Congress 2023

27 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of cardiac troponin elevations in athletes following running, cycling, or walking events
thumbnail
Congress Presentation
Exercise-induced cardiac troponins in long-distance walkers: a preliminary observation.
thumbnail
Congress Presentation
Exercise-induced cardiac troponin I in an individual with progressive coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources